{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:33:44Z","timestamp":1790883224336,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ijcard.2017.08.049","type":"journal-article","created":{"date-parts":[[2017,8,26]],"date-time":"2017-08-26T16:31:20Z","timestamp":1503765080000},"page":"234-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation"],"prefix":"10.1016","volume":"249","author":[{"given":"Steffen","family":"Gloekler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos C.","family":"Koskinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kleinecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Nietlispach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.08.049_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9400","article-title":"A randomized controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study","volume":"9","author":"Hobbs","year":"2005","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0010","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0140-6736(11)61514-6","article-title":"Atrial fibrillation","volume":"379","author":"Lip","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0015","first-page":"e28","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0020","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0025","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"CRYSTAL AF investigators. Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0030","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.amjcard.2005.11.019","article-title":"Histology of vascular myocardial wall of left atrial body after pulmonary venous incorporation","volume":"97","author":"Douglas","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0045","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jcmg.2014.08.009","article-title":"The left atrial appendage: anatomy, function, and noninvasive evaluation","volume":"7","author":"Beigel","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0050","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1378\/chest.124.6.2356","article-title":"Elimination of the left atrial appendage to prevent stroke or embolism? Anatomic, physiologic, and pathophysiologic considerations","volume":"124","author":"St\u00f6llberger","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ccd.21983","article-title":"Is the left atrial appendage more than a simple appendage","volume":"74","author":"Hara","year":"2009","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118822","article-title":"Left atrial appendage morphology in patients with suspected cardiogenic stroke without known atrial fibrillation","volume":"10","author":"Korhonen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2012.04.032","article-title":"Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study","volume":"60","author":"Di Biase","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCIMAGING.113.001317","article-title":"Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation","volume":"7","author":"Yamamoto","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0075","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.hrthm.2013.01.036","article-title":"Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores","volume":"10","author":"Kimura","year":"2013","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1054-8807(00)00030-2","article-title":"Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography","volume":"9","author":"Shirani","year":"2000","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCEP.111.962720","article-title":"Left atrial anatomy revisited","volume":"5","author":"Ho","year":"2012","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.1949.02900440011003","article-title":"Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli","volume":"140","author":"Madden","year":"1949","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1160\/th15-07-0532","article-title":"Prevalence of left atrial thrombus in patients with non-valvular atrial fibrillation. A systematic review and meta-analysis of the literature","volume":"115","author":"Di Minno","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","article-title":"Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study","volume":"25","author":"Stoddard","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0115","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1253\/circj.CJ-15-0524","article-title":"Left atrial appendage closure reduces the incidence of postoperative cerebrovascular accident in patients undergoing cardiac surgery","volume":"79","author":"Kato","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/clc.4960161008","article-title":"Echocardiographic study of left atrial thrombi in mitral stenosis","volume":"16","author":"Conradie","year":"1993","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.3.3.363","article-title":"Mural thrombosis and arterial embolism in mitral stenosis: a clinicopathologic study of fifty-one cases","volume":"3","author":"Jordan","year":"1951","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0135","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0140","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0145","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0150","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0155","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0160","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0165","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0170","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.113.002601","article-title":"National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation","volume":"129","author":"Dlott","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0175","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0185","first-page":"1","article-title":"Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation","volume":"0","author":"Camm","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/STROKEAHA.109.566950","article-title":"Persistent use of secondary preventive drugs declines rapidly during the first 2years after stroke","volume":"41","author":"Glader","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0195","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0200","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/01.CIR.0000015698.54752.6D","article-title":"Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience","volume":"105","author":"Sievert","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ccd.10660","article-title":"Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation","volume":"60","author":"Meier","year":"2003","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0022-5223(99)70052-8","article-title":"Impact of the maze procedure on the stroke rate in patients with atrial fibrillation","volume":"118","author":"Cox","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0215","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1010-7940(00)00419-X","article-title":"The left atrial appendage: our most lethal human attachment! Surgical implications","volume":"17","author":"Johnson","year":"2000","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0220","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0735-1097(03)00954-9","article-title":"Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study","volume":"42","author":"Garc\u00eda-Fern\u00e1ndez","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0225","first-page":"45","article-title":"Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III","volume":"3","author":"Whitlock","year":"2014","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0230","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0235","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jtcvs.2011.07.052","article-title":"Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial","volume":"142","author":"Ailawadi","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0240","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4244\/EIJV8I9A167","article-title":"The Amplatzer\u2122 cardiac plug 2 for left atrial appendage occlusion: novel features and first-in-man experience","volume":"8","author":"Freixa","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0245","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00392-015-0828-1","article-title":"Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation","volume":"104","author":"Gloekler","year":"2015","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0250","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/europace\/euu174","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"16","author":"Meier","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0255","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2007.02.035","article-title":"Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation","volume":"49","author":"Sick","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jacc.2012.06.046","article-title":"Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience","volume":"62","author":"Bartus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0265","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2014.03.057","article-title":"Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium","volume":"64","author":"Price","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0270","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jcmg.2015.02.002","article-title":"Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography","volume":"8","author":"Wunderlich","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2015.09.020","article-title":"Cardiac computed tomography angiography for left atrial appendage closure","volume":"32","author":"Saw","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0280","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jce.12909","article-title":"Comparing measurements of CT angiography, TEE, and fluoroscopy of the left atrial appendage for percutaneous closure","volume":"27","author":"Saw","year":"2016","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0285","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/STROKEAHA.110.611293","article-title":"Dual-enhanced cardiac CT for detection of left atrial appendage thrombus in patients with stroke: a prospective comparison study with transesophageal echocardiography","volume":"42","author":"Hur","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0290","first-page":"462","article-title":"Comparison of imaging techniques to assess appendage anatomy and measurements for left atrial appendage closure device selection","volume":"26","author":"L\u00f3pez-M\u00ednguez","year":"2014","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0295","first-page":"683","article-title":"Ad hoc percutaneous left atrial appendage closure","volume":"25","author":"Nietlispach","year":"2013","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0300","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jcin.2016.04.019","article-title":"Predictors of early (1-week) outcomes following left atrial appendage closure with Amplatzer devices","volume":"9","author":"Koskinas","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0305","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ccd.25354","article-title":"Amplatzer left atrial appendage occlusion through a patent foramen ovale","volume":"84","author":"Koermendy","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0310","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcin.2014.04.014","article-title":"Periprocedural intracardiac echocardiography for left atrial appendage closure: a dual-center experience","volume":"7","author":"Berti","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0315","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ccd.24872","article-title":"Amplatzer left atrial appendage occlusion: single center 10-year experience","volume":"82","author":"Nietlispach","year":"2013","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0320","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/ehjci\/jev067","article-title":"Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure","volume":"16","author":"Saw","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0325","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4244\/EIJV12I1A19","article-title":"Appraising the safety and efficacy profile of left atrial appendage closure in 2016 and the future clinical perspectives. Results of the EAPCI LAAC survey","volume":"12","author":"Santucci","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0330","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0335","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0340","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with Watchman left atrial appendage closure technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0350","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0355","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","article-title":"Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis","volume":"65","author":"Holmes","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0360","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0365","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0370","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2016.10.010","article-title":"Post-FDA approval, initial US clinical experience with Watchman left atrial appendage closure for stroke prevention in atrial fibrillation","volume":"69","author":"Reddy","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0375","series-title":"Oral Presentation, TCT Meeting, Washington DC, USA","article-title":"The AMULET Study: a multicenter, prospective registry of the Amulet left atrial appendage closure device for stroke prevention in patients with atrial fibrillation","author":"Hildick-Smith","year":"2016"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0380","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2013.01.061","volume":"61","author":"Alli","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0385","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.jacc.2015.09.084","article-title":"Time to cost-effectiveness following stroke reduction strategies in AF: warfarin versus NOACs versus LAA closure","volume":"66","author":"Reddy","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0395","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jcin.2016.04.038","article-title":"\u201cOne-Stop Shop\u201d: safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion","volume":"9","author":"Attinger-Toller","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0400","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ccd.26170","article-title":"2015 ACC\/HRS\/SCAI left atrial appendage occlusion device societal overview: a professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions","volume":"86","author":"Masoudi","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0405","series-title":"Late Breaking Clinical Trial","article-title":"Percutaneous left atrial appendage closure vs. oral anticoagulation: a propensity score matched study of 1000 patients with atrial fibrillation. Euro PCR 2017","author":"Gloekler","year":"2017"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0410","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0415","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4244\/EIJV12I1A18","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies","volume":"12","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0425","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0430","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0435","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0440","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0445","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.04.063","article-title":"Paradoxical Embolism","volume":"64","author":"Windecker","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0450","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the Watchman randomized trial experience","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0455","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/CIRCULATIONAHA.112.000920","article-title":"Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation","volume":"127","author":"Singh","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.08.049_bb0460","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/0272989X15593083","article-title":"A decision analysis of percutaneous left atrial appendage occlusion relative to novel and traditional oral anticoagulation for stroke prevention in patients with new-onset atrial fibrillation","volume":"36","author":"Micieli","year":"2016","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0465","doi-asserted-by":"crossref","first-page":"1355.e9","DOI":"10.1016\/j.cjca.2016.02.056","article-title":"Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation patients with contraindications to anticoagulation","volume":"32","author":"Saw","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.08.049_bb0470","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/euv412","article-title":"Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin","volume":"18","author":"Reddy","year":"2016","journal-title":"Europace"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317336203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317336203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T14:05:29Z","timestamp":1719410729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317336203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":94,"alternative-id":["S0167527317336203"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.049","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}